Cancer Cell International

Table 1 Clinicopathological significance of TMED3 expression in breast cancer

From: RETRACTED ARTICLE: TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p

Characteristics	N	TMED3 expression		χ²	p
Characteristics	N	Low	High	χ²	p
Breast cancer	112	53	59	45.551	0.000
Matched normal	112	100	12	45.551	0.000
Age (years)
< 50	49	24	25	0.096	0.849
≥ 50	63	29	34	0.096	0.849
Tumor size (cm)
≤ 2	38	17	21	0.154	0.842
> 2	74	36	38	0.154	0.842
ER
+	85	41	44	8.703	0.003
−	27	11	16	8.703	0.003
PR
+	54	38	16	3.386	0.050
−	58	31	27	3.386	0.050
Her-2
+	50	23	27	4.579	0.037
−	62	41	21	4.579	0.037
M classification
M0	78	38	40	0.201	0.685
M1–3	34	15	19	0.201	0.685
N classification
N0	51	14	37	14.831	0.000
N1–3	61	39	22	14.831	0.000
Subtype
Luminal A	15	7	8	0.042	1.000
Luminal B	56	27	29
Her-2	17	8	9
Triple-negative	24	11	13
Grading
I	21	12	9	3.492	0.181
II	55	29	31
III	36	12	24
Staging
I + II	67	37	30	4.177	0.054
III + IV	45	16	29	4.177	0.054

Back to article page

ISSN: 1475-2867

Contact us

General enquiries: journalsubmissions@springernature.com